ArticleiScience2026
ADSPAO: Enhanced artemisinin optimization for multi-threshold segmentation of chronic obstructive pulmonary disease.
Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic obstructive pulmonary disease (COPD) poses a significant threat to global public health, with its diagnosis heavily reliant on accurate segmentation of medical computed tomography (CT) images. However, current segmentation methods suffer from limited optimization efficiency, accuracy, and high computational costs. To address these issues, this paper proposes an improved artemisinin optimization algorithm (ADSPAO), which incorporates spiral propagation (SP) and adaptive delivery (AD) strategies to enhance local exploitation and global exploration, respectively. Experimental comparisons on the IEEE CEC2017 benchmark show that ADSPAO exhibits superior robustness and stability across various function types. Furthermore, the algorithm is applied to multi-threshold segmentation of COPD CT images using Renyi entropy as the fitness function. Results demonstrate that ADSPAO achieves better segmentation performance in terms of peak signal to noise ratio (PSNR), structural similarity (SSIM), and feature similarity (FSIM) compared to other methods, offering an efficient and reliable solution for medical image segmentation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.